StonvexLoading…
StonvexStonvexStonvexCore line items from FRT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.28B | $1.20B | $1.13B | $1.07B |
Operating Income | $602.20M | $472.36M | $406.47M | $526.41M |
Net Income | $411.08M | $295.21M | $236.99M | $385.49M |
EPS (Diluted) | $4.68 | $3.42 | $2.80 | $4.71 |
Total Assets | $9.13B | $8.52B | $8.44B | $8.23B |
Total Liabilities | $5.63B | $5.10B | $5.21B | $5.02B |
Cash & Equivalents | $107.42M | $123.41M | $250.82M | $85.56M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 86.27M | 85.67M | 82.78M | 81.34M |